Share your insight and experience to improve patent prosecution in biotechnology areas at the United States Patent and Trademark Office’s (USPTO) next Biotechnology, Chemical, and Pharmaceutical Customer Partnership (BCP) Meeting on Tuesday, March 28, from 10 a.m. to 5 p.m. ET. The meeting will be held in person at USPTO headquarters in Alexandria, Virginia, and will also be available online.
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality of the agency’s products and services. The meeting’s discussion topics include:
- Nonstatutory double patenting
- Declaration practice under 37 CFR 1.132
- Patent term extension
- Cancer Moonshot Expedited Examination pilot program
- Artificial intelligence/machine learning in biotechnology
- WIPO Standard ST.26 (for nucleotide and amino acid sequence listings)
BCP Customer Partnership
10:00 AM - 5:00 PM Tuesday, March 28, 2023 (UTC-04:00) Eastern Time (US & Canada)
Join link: https://uspto.webex.com/uspto/j.php?MTID=m3c2eb88afe8a554b353ffa2a235d4a50
Webinar number: 2763 789 9750
Webinar password: virtual (8478825 from phones and video systems)
The USPTO looks forward to hearing the individual views of its customers and does not intend to use this forum to seek or arrive at any consensus advice.
For questions and comments regarding this event, please email USPTOBCP1600@USPTO.GOV.
If you are an individual with a disability and would like to request a reasonable accommodation, please submit your request to the contact information listed above.